Benutzer: Gast  Login
Titel:

c-Met in chromophobe renal cell carcinoma.

Dokumenttyp:
Journal Article; Article
Autor(en):
Erlmeier, Franziska; Ivanyi, Philipp; Hartmann, Arndt; Autenrieth, Michael; Wiedemann, Max; Weichert, Wilko; Steffens, Sandra
Abstract:
c-Met plays a role as a prognostic marker in clear cell renal cell carcinoma. In addition, recently the tyrosine kinase inhibitor cabozantinib targeting c-Met was approved for the treatment of advanced renal cell carcinoma (RCC). In contrast to clear cell RCC, little is known about c-Met expression patterns in rarer RCC subtypes. The aim of this study was to evaluate the prevalence, distribution and prognostic impact of c-Met expression on chromophobe (ch)RCC. Patients who underwent renal surger...     »
Zeitschriftentitel:
Med Oncol
Jahr:
2017
Band / Volume:
34
Heft / Issue:
2
Seitenangaben Beitrag:
15
Sprache:
eng
Volltext / DOI:
doi:10.1007/s12032-016-0874-1
PubMed:
http://view.ncbi.nlm.nih.gov/pubmed/28035577
Print-ISSN:
1357-0560
TUM Einrichtung:
Institut für Allgemeine Pathologie und Pathologische Anatomie; Urologische Klinik und Poliklinik
 BibTeX